Gene Therapy for Alzheimer's Disease and Spinal Cord Injury

Gene Therapy for Alzheimer's Disease and Spinal Cord Injury presented by Mark Tuszynski, M.D., Ph.D. Professor of Neurosciences & Director for the Center of Neural Repair

This laboratory studies anatomical, electrophysiological and functional plasticity in the intact and injured adult central nervous system. We focus in particular on the functional role of growth factors in modulating plasticity. Models studied in the lab include: 1) mechanisms of learning and memory in the intact adult brain, 2) plasticity and cell degeneration in models of aging and Alzheimer's disease, and 3) axonal plasticity and regeneration after spinal cord injury. In rodent and primate models of spinal cord injury, we examine the influences of growth factors and extracellular matrix molecules in modulating axonal responses to injury and the ability of these substances to promote axonal regeneration. In models of basal forebrain and cortical degeneration in rodents and primates, the ability of neurotrophic factors delivered by gene therapy to modulate cellular plasticity and survival. These studies are relevant to the understanding of aging and neuronal loss in Alzheimer's disease and Parkinson's Disease. In the intact brain, we examine changes in neuronal structure and function that occur during normal learning, and the role of neurotrophic factors in modulating these changes.


Try this Search Engine
Search Biosolutions